Limited efficacy of a nonrestricted intervention on antimicrobial prescription of commonly used antibiotics in the hospital setting: Results of a randomized controlled trial

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 27, Issue 7, 2008, Pages 597-605

  Masia M ^a   Matoses, C ^a   Padilla, S ^a   Murcia, A ^a   Sanchez V ^a   Romero, I ^a   Navarro, A ^a   Hernandez I ^b   Gutierrez F ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

^b MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; CARBAPENEM DERIVATIVE; CEFTRIAXONE; CLOXACILLIN; IMIPENEM; LEVOFLOXACIN; MACROLIDE; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN;

ADULT; AGED; ARTICLE; BACTERIAL MENINGITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COST; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEBRILE NEUTROPENIA; FEMALE; HOSPITAL INFECTION; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; PANCREATITIS; PHARMACIST; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; SEPSIS; STAPHYLOCOCCUS INFECTION;

AGED; ANTI-BACTERIAL AGENTS; CARBAPENEMS; COUNSELING; DRUG UTILIZATION; FEMALE; GUIDELINE ADHERENCE; HOSPITALS; HUMANS; MALE; MIDDLE AGED; OFLOXACIN; ORGANIZATIONAL POLICY; PRESCRIPTIONS, DRUG; VANCOMYCIN;

EID: 45449099703     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-008-0482-x     Document Type: Article

References (37)

1. Arason V, Kristinsson K, Sigurdsson J, Stefansdottir G, Molstad S, Gudmundsson S (1996) Do antimicrobials increase the carriage rate of penicillin-resistant pneumococci in children? Cross-sectional prevalence study. BMJ 313:387-391
2. Albrich W, Monnet D, Harabarth S (2004) Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes. Emerg Infect Dis 10:514-517
3. Ho PL, Tse WS, Tsang KWT, Kwok TK, Ng TK, Cheng VCC, Chan RM (2001) Risk factors for acquisition of levofloxacin-resistant Streptococcus pneumoniae: a case-control study. Clin Infect Dis 32:701-707
4. Nava JM, Bella F, Garau J, Lite J, Morera MA, Marti C, Fontanals D, Font B, Pineda V, Uriz S (1994) Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: a population-based study. Clin Infect Dis 19:884-890
5. Samore M, Magill M, Alder S, Severina E, Morrison-de Boer L, Lyon J, Carroll K, Leary J, Stone MB, Bradford D, Reading J, Tomasz A, Sande MA (2001) High rates of multiple antibiotic resistance in Streptococcus pneumoniae from healthy children living in isolated rural communities: association with cephalosporin use and intrafamilial transmission. Pediatrics 108:856-865
6. Tan TQ, Mason EO Jr, Kaplan SL (1993) Penicillin-resistant systemic pneumococcal infections in children: a retrospective case-control study. Pediatrics 92:761-767
7. Guillemot D, Maison P, Carbon C, Balkau B, Vauzelle-Kervroedan F, Sermet C, Bouvenot G, Eschwege E (1998) Trends in antimicrobial drug use in the community-France, 1981-1992. J Infect Dis 177:492-497
8. Gonzales R, Steiner JF, Sande MA (1997) Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA 278:901-904
9. Fridkin SK, Steward CD, Edwards JR, Pryor ER, McGowan JE Jr, Archibald LK, Gaynes RP, Tenover FC (1999) Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. Clin Infect Dis 29:245-252
10. Bantar C, Sartori B, Saúl M et al (2001) Alarming misuse of antibiotics in a hospital from Argentina. Abstract no. A-69. In: Program and abstracts of the 101st general meeting of the American Society for Microbiology, Orlando, FL, USA
11. John JF Jr, Fishman NO (1997) Programmatic role of the infectious diseases physician in controlling antimicrobial costs in the hospital. Clin Infect Dis 24:471-485
12. Pestotnik SL, Classen DC, Evans RS, Burke JP (1996) Implementing antibiotic practice guidelines through computer-assisted decision support: clinical and financial outcomes. Ann Intern Med 124:884-890
13. Slama TG, Amin A, Brunton SA, File TM Jr, Milkovich G, Rodvold KA, Sahm DF, Varon J, Weiland D Jr (2005) A clinician's guide to the appropriate and accurate use of antibiotics: the Council for Appropriate and Rational Antibiotic Therapy (CARAT) criteria. Am J Med 118(Suppl 7A):1-6
14. Belongia EA, Knobloch MJ, Kieke BA, Davis JP, Janette C, Besser RE (2005) Impact of statewide program to promote appropriate antimicrobial drug use. Emerg Infect Dis 11:912-920
15. Belongia EA, Sullivan BJ, Chyou PH, Madagame E, Reed KD, Schwartz B (2001) A community intervention trial to promote judicious antibiotic use and reduce penicillin-resistant Streptococcus pneumoniae carriage in children. Pediatrics 108:575-583
16. Perz JF, Craig AS, Coffey CS, Jorgensen DM, Mitchel E, Hall S, Schaffner W, Griffin MR (2002) Changes in antibiotic prescribing for children after a community-wide campaign. JAMA 287:3103-3109
17. Welschen I, Kuyvenhoven MM, Hoes AW, Verheij TJ (2004) Effectiveness of a multiple intervention to reduce antibiotic prescribing for respiratory tract symptoms in primary care: randomised controlled trial. BMJ 329:431
18. Doyne EO, Alfaro MP, Siegel RM, Atherton HD, Schoettker PJ, Bernier J, Kotagal UR (2004) A randomized controlled trial to change antibiotic prescribing patterns in a community. Arch Pediatr Adolesc Med 58:577-583
19. Finkelstein JA, Davis RL, Dowell SF, Metlay JP, Soumerai SB, Rifas-Shiman SL, Higham M, Miller Z, Miroshnik I, Pedan A, Platt R (2001) Reducing antibiotic use in children: a randomized trial in 12 practices. Pediatrics 108:1-7
20. Macfarlane J, Holmes W, Gard P, Thornhill D, Macfarlane R, Hubbard R (2002) Reducing antibiotic use for acute bronchitis in primary care: blinded, randomised controlled trial of patient information leaflet. BMJ 324:91-94
21. Briel M, Langewitz W, Tschudi P, Young J, Hugenschmidt C, Bucher HC (2006) Communication training and antibiotic use in acute respiratory tract infections. A cluster randomised controlled trial in general practice. Swiss Med Wkly 136:241-247
22. Shlaes DM, Gerding DN, John JF Jr, Craig WA, Bornstein DL, Duncan RA, Eckman MR, Farrer WE, Greene WH, Lorian V, Levy S, McGowan JE Jr, Paul SM, Ruskin J, Tenover FC, Watanakunakorn C (1997) Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis 25:584-599
23. Cook PP, Catrou PG, Christie JD, Young PD, Polk RE (2004) Reduction in broad-spectrum antimicrobial use associated with no improvement in hospital antibiogram. J Antimicrob Chemother 53:853-859
24. Bantar C, Sartori B, Vesco E, Heft C, Saul M, Salamone F, Oliva ME (2003) A hospitalwide intervention program to optimize the quality of antibiotic use: impact on prescribing practice, antibiotic consumption, cost savings, and bacterial resistance. Clin Infect Dis 37:180-186
25. Paul M, Andreassen S, Tacconelli E, Nielsen AD, Almanasreh N, Frank U, Cauda R, Leibovici L (2006) Improving empirical antibiotic treatment using TREAT, a computerized decision support system: cluster randomized trial. J Antimicrob Chemother 58:1238-1245
26. Martin C, Ofotokun I, Rapp R, Empey K, Armitstead J, Pomeroy C, Hoven A, Evans M (2005) Results of an antimicrobial control program at a university hospital. Am J Health Syst Pharm 62:732-738
27. Bassetti M, Di Biagio A, Rebesco B, Amalfitano ME, Topal J, Bassetti D (2001) The effect of formulary restriction in the use of antibiotics in an Italian hospital. Eur J Clin Pharmacol 57:529-534
28. Woodward RS, Medoff G, Smith MD, Gray JL 3rd (1987) Antibiotic cost savings from formulary restrictions and physician monitoring in a medical-school-affiliated hospital. Am J Med 83:817-823
29. Lopez-Medrano F, San Juan R, Serrano O, Chaves F, Lumbreras C, Lizasoain M, Herreros de Tejada A, Aguado JM (2005) Impact of a non-compulsory antibiotic control program (PACTA): cost reductions and decreases in some nosocomial infections. Enferm Infecc Microbiol Clin 23:186-190
30. Bantar C, Franco D, Heft C, Vesco E, Arango C, Izaguirre M, Oliva ME (2006) Does a reduction in antibiotic consumption always represent a favourable outcome from an intervention program on prescribing practice. Int J Infect Dis 10:231-235
31. Stone SP, Cooper BS, Kibbler CC, Cookson BD, Roberts JA, Medley GF, Duckworth G, Lai R, Ebrahim S, Brown EM, Wiffen PJ, Davey PG (2007) The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection. J Antimicrob Chemother 59:833-840
32. Fraser GL, Stogsdill P, Dickens JD Jr, Wennberg DE, Smith RP Jr, Prato BS (1997) Antibiotic optimization. An evaluation of patient safety and economic outcomes. Arch Intern Med 157:1689-1694
33. Senn L, Burnand B, Francioli P, Zanetti G (2004) Improving appropriateness of antibiotic therapy: randomized trial of an intervention to foster reassessment of prescription after 3 days. J Antimicrob Chemother 53:1062-1067
34. Davey P, Brown E, Fenelon L, Finch R, Gould I, Hartman G, Holmes A, Ramsay C, Taylor E, Wilcox M, Wiffen P (2005) Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev: CD003543
35. Bailey TC, Ritchie DJ, McMullin ST, Kahn M, Reichley RM, Casabar E, Shannon W, Dunagan WC (1997) A randomized, prospective evaluation of an interventional program to discontinue intravenous antibiotics at two tertiary care teaching institutions. Pharmacotherapy 17:277-281
36. Vander Stichele RH, Elseviers MM, Ferech M, Blot S, Goossens H (2006) Hospital consumption of antibiotics in 15 European countries: results of the ESAC retrospective data collection (1997-2002). J Antimicrob Chemother 58:159-167
37. Dellit TH, Owens RC, McGowan JE Jr, Gerding DN, Weinstein RA, Burke JP, Huskins WC, Paterson DL, Fishman NO, Carpenter CF, Brennan PJ, Billeter M, Hooton TM (2007) Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 44:159-177